Documente Academic
Documente Profesional
Documente Cultură
Males Females
1. Prostate 1. Breast
2. Colorectal 2. Colorectal
3. Melanoma 3. Melanoma
4. Lung 4. Lung
5. Head and neck 5. Uterus
6. Lymphoma 6. Lymphoma
7. Leukaemia 7. Thyroid
8. Bladder 8. Leukaemia
9. Kidney 9. Ovary
10. Pancreas 10. Pancreas
From Cancer in Australia: An Overview, 2014, Cancer series no. 90. Cat. no. CAN 88. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. From Table 3.2 5
Cancer mortality
Males Females
1. Lung 1. Lung
2. Prostate 2. Breast
3. Colorectal 3. Colorectal
4. Pancreas 4. Pancreas
5. Unknown 5. Unknown
6. Melanoma 6. Ovary
7. Liver 7. Leukaemia
8. Leukaemia 8. Other digestive organs
9. Oesophagus 9. Lymphoma
10. Lymphoma 10. Brain
From Cancer in Australia: An Overview, 2014, Cancer series no. 90. Cat. no. CAN 88, Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. From Table 3.2 6
Rates in Indigenous and non-
Indigenous Australians
7
Trends in 5 year survival
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 8
Normal Cell Division and Proliferation
Cells grow and divide according to their tissue
type
Cell size and number are regulated and
maintained
No inflammation
12
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 4-14B
DNA
DNA
Genetic information
Genes segments of DNA
Remains in nucleus
13
Marieb & Hoehn, Human Anatomy and Physiology, 2007, Fig 2.22
DNA, Genes and Chromosomes
14
Huether & McCance, Understanding Pathophysiology, 2008, Fig 2-6
Cell cycle
15
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 5-3
Cell cycle
Interphase:
From cell formation to cell division (cells not actually
dividing)
G1 (gap 1)
Main phase
Active growth and production of proteins
S (synthesis)
DNA is replicated Synthesis = production of molecules
G2 (gap 2)
proteins and enzymes needed for cell division are produced
16
Cell cycle
Mitotic phase
Mitosis: division of nucleus to form two identical
daughter cells
G2/M checkpoint
Progresses into M phase only if:
DNA replication is completed
Chromosomes are intact
18
Tumour Growth
A tumour (neoplasm) is a mass or growth
which can arise from normal tissue
Tumours can be benign or malignant
Benign tumours are non-invasive and do not
spread
Malignant tumours have the capacity to invade
and infiltrate surrounding tissue, so extend
beyond the tissue of origin and can
metastasise or spread to other sites
Benign and Malignant
Benign tumours are composed of well
differentiated cells
mature cells that resemble the tissue of origin
26
Genetic mutations
Carcinogens
Genetic
mutations
Inheritance of
mutated genes Cancer
(5% of cases)
27
Growth and antigrowth signals
Cancer cells may
stimulate their own
growth
Secrete growth factors
Increased number of
growth factor receptors
Genes that regulate
apoptosis
28
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 36-5
Normal regulatory genes
Proto-oncogenes:
Regulate cell growth and division
Tumour suppressor genes eg p53
Slow down proliferation
Direct cell repair when DNA is damaged
Other regulatory genes eg Caretaker genes
Help repair DNA
Induce apoptosis when repair not completed
29
30
http://www.cancer.gov/cancertopics/understandingcancer/cancer/page47, Last accessed Sep 2014
DNA damage, repair, and cancer
Cancer
38
39
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 36-9
40
Kumar et al, Robbins & Cotran Pathologic Basis of Disease, 8th edn, Fig 7-32
41
Cancer growth
Growth
Cells grow and multiply independently of normal cell
controls
Angiogenesis
Formation of new blood vessels
Metastasis
Spread to other distant tissues or organs
42
Cancer growth
Loss of normal arrangement of cells
Variation in cell shape and size
Increase in size of nucleus (increase in DNA)
Increase in mitotic activity (cell division)
Invasion of surrounding tissues
43
Angiogenesis
Mainly in more advanced cancers
Tumour develops its own blood supply
Due to high metabolic rate
Can facilitate metastasis
44
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 36-14
Majno & Joris, Cells, Tissues, and Disease,
2nd edn, 2004, Fig 26-57 45
Metastasis
Ability to migrate and spread
to distant organs
Via blood vessels (mainly
veins)
Via lymphatic vessels and
body cavities (mainly
peritoneal cavity)
46
Herlihy, The Human Body in Health and Illness, 2007, p350
Metastasis
Most common sites are liver, lungs, bone and brain
Most common sites of metastasis differ for each primary
cancer type
49
Multistep nature of metastasis
50
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 36-16
51
Production of new formed elements
All blood cells are:
Produced in the red bone marrow
Derived from stem cells (haematopoietic stem cell)
52
53
Vander, Human Physiology, Fig 12.71
Red bone marrow
54
Silverthorn, Human Physiology, 2001, Fig 16.5c
Immune system and cancer
Cytotoxic T lymphocytes
Natural killer cells
Macrophages
Inflammation
55
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 13-5
Macrophages
Cells that engulf and
remove debris, cells etc
Process of phagocytosis
56
Germann & Stanfield, Principles of Human Physiology, 2002, Fig 22.4
Natural killer (NK) cells
Type of lymphocytes
Lysis of cancer cells
Release chemicals that
disintegrates the cell
57
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 12-2B
Inflammation and cancer
Chronic inflammation increases risk of cancer
Inflammatory cells release cyclo-oxygenase 2
(COX-2)
Associated with some cancers
eg colorectal
Aspirin: anti-inflammatory
58
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 36-19
Stress and Cancer
Stress, immunity and cancer
Excess cortisol suppresses some functions of the
immune system
Link with the development of cancer
In cancer patients, stress can increase growth and
spread of cancer
59
60
Carcinogens
Infectious agents e.g.
viruses, bacteria
Environmental factors e.g.
ionizing radiation,
iatrogenic exposure
Lifestyle factors e.g.
obesity, alcohol, physical
inactivity, nutritional
factors
61
Mann & Truswell, Essentials of Human Nutrition, 3rd edn, 2007, Table 21.2
Infectious agents
62
Ionizing radiation
63
Iatrogenic exposure
64
Lifestyle factors that increase risk
Modifiable risk factors for cancer
Obesity
Sedentary lifestyle
Alcohol consumption
Smoking
Dietary eg low fibre, low intake of fruit and vegetables, high salt,
iron, cooking process eg charring meat, aflatoxin
Hyperglycaemia, hyperinsulinaemia
Chronic inflammation
Stress
Lifestyle modifications
66
Mann & Truswell, Essentials of Human Nutrition, 3rd edn, 2007, Table 21.4
67
Clinical features
Mainly in advanced stages
Pain Local effects
Fatigue
Cachexia
Systemic effects
Anorexia
Anaemia
Thrombocytopenia
Infection
68
Pain
Usually only when cancer is well advanced
Related to
Direct pressure of tumour on sensory receptors
Obstruction
Tumour growing inside a lumen, or compressing the
lumen from outside
Inflammation
Tissue damage
69
Gould, Pathophysiology for the Health Professions, 2006, Fig 5-3
Fatigue
Persistent tiredness
Most common symptom
Sleep disturbances
Alterations in cytokines
Psychosocial factors
Nutritional status
Level of physical activity
70
Cachexia
Severe tissue wasting (fat and muscle)
Fatigue and weakness
Anorexia
Pain
71
Copstead & Banasik, Pathophysiology, 4th edn, Fig 7-18
Anorexia
Loss of appetite
(not = anorexia nervosa)
Very little appetite due to various factors
including:
Altered taste sensation
Nausea and vomiting
Psychological concerns
Some of these are due to cancer treatments
72
73
Craft & Gordon, Understanding Pathophysiology 2nd ed 2015, Fig 36-26
Anaemia
Oxygen-carrying capacity is low due to:
Inadequate food intake, chronic bleeding and iron loss
Cancer in bone marrow or depression of bone marrow
via cancer treatments
Causing insufficient number of erythrocytes
74
Thrombocytopenia
Low platelet count
Cancer in bone marrow or depression of bone
marrow via cancer treatments
Causing insufficient number of platelets
Prone to haemorrhage
Contributes to iron loss and anaemia
75
Infections
Immune system becomes weakened
Infection often fatal
Due to
Cancer in bone marrow or depression of bone
marrow via cancer treatments
Causing insufficient number of leucocytes: leucopenia
76
77
Treatment
Surgery
Radiation therapy
Antineoplastic medications
Cytotoxic drugs
Antibodies
Hormonal
Palliative care
78
Surgery
Removal of the tumour
Usually removal of a margin (take some
apparently healthy tissue around the growth as
well)
79
Radiation therapy
X-rays or gamma rays
Causes damage to cancer cell DNA, inducing
apoptosis
80
Mader, Human Biology, 2006, Fig 24.9
Cytotoxic drugs
Use of cytotoxic or antineoplastic drugs that target
rapidly dividing cells
Used after surgery to destroy any remaining cells (adjuvant
chemotherapy)
Used before surgery to decrease tumour size (neoadjuvant
chemotherapy)
Often a few drugs are used together
eg Fluorouracil in combination with other drugs
81
Antibodies,
drugs that modify the immune system
Boosts the immune defences against cancer
cells
Activate immune system components
Eg Filgrastim increases production of neutrophils
82
Hormonal therapy
Some cancers of the reproductive system
are hormone dependant
Drugs that block activity or production of
hormones may be used
e.g. Tamoxifen blocks effects of oestrogen
83
Palliative care
Treatment of patients symptoms when
other treatment options are not suitable
Includes pain medications
84
Side effects of cancer therapies (1)
Rapidly dividing cells are vulnerable
Hair follicles
Alopecia, usually temporary
Gastrointestinal tract
Causing nausea, vomiting, anorexia, diarrhoea
Anti-emetics eg ondansetron
Skin and mucous membranes
Resulting in infections
Prevention, early intervention
85
Side effects of cancer therapies (2)
Bone marrow
Causing leucopenia, thrombocytopenia, anaemia
Treated using transfusions, erythropoietin (EPO)
Reproductive system
Causing decreased fertility, early menopause
Addressed using sperm or embryo banking
86
Lymphatic Vessels
88
http://www.vibraq.com/images/lymph_1.jpg , Last accessed Sep 2014
89
Main cancers for Australia
Colorectal
Breast
Prostate
Melanoma
Lung
National Cancer Screening Programs
Breast cancer
Bowel (colorectal) cancer
Cervical cancer
Risk factors
Low dietary fibre, high fat intake
92
http://www.sciencedaily.com/releases/2008/03/080324202016.htm, Last accessed Sep 2014
Colorectal cancer clinical features
Few symptoms until advanced stage
93
Colorectal cancer detection
Currently <40% of cases detected early
No early warning symptoms
Remains confined for long period before invading
bowel wall and other organs
94
Incidence: Colorectal
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 95
Mortality: Colorectal
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 96
Breast cancer
Usually arises from epithelial cells lining the small
ducts involved in milk production
Risk factors:
Early menarche and late menopause
No pregnancy, or first pregnancy late in life; little
breast feeding
Family history / genetics
Hormone replacement therapy
97
Breast cancer diagnosis
Self examination
Mammogram
from 40 years
MRI for younger
women in high-
risk groups
Needle biopsy
http://www.cancerresearchuk.org/cancer-help/type/breast-
99
cancer/treatment/number-stages-of-breast-cancer, Last accessed Sep 2014
Prostate cancer
Most are adenocarcinomas
Risk factors
Family history / genetics
Dietary factors eg high fat intake
100
Prostate cancer clinical features
If advanced, tumour compresses urethra
causing urinary symptoms
e.g. dysuria, urinary infection, frequent urination
101
Prostate cancer diagnosis
Digital rectal examination
Prostate serum antigen (PSA) levels in the
blood
Biopsy
http://m.medlineplus.gov/ency/presentations/100046.htm?
102
page=2, Last accessed Sep 2014
Incidence: Prostate and Breast
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 103
Mortality: Prostate and Breast
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 104
Melanoma
Malignant tumour arising from melanocytes
Very rapid metastasis, resistant to
chemotherapy
Risk factors
Recurring exposure to UV light
Sunburn in childhood
Fair skin
Family history
105
Melanoma
detection
Asymmetry
Border irregularity
Colour variation
Diameter >6mm
Evolving over time
or elevation
106
Mader, Human Biology, 2006, Fig 24.8
Incidence: Lung
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 107
Mortality: Lung
From Cancer in Australia: An Overview, 2012, Cancer series no. 74. Cat. no. CAN 70. Canberra. Australian
Institute of Health and Welfare & Australasian Association of Cancer Registries. 108